Histological Classification of Mesenchymal Tumors of Skin and Soft Tissues of Domestic Animals 英名 提案 候補 TUMORS of FIBROUS TISSUE 線維組織性腫瘍 線維組織性腫瘍/ 線維組織の腫瘍 1

Total Page:16

File Type:pdf, Size:1020Kb

Histological Classification of Mesenchymal Tumors of Skin and Soft Tissues of Domestic Animals 英名 提案 候補 TUMORS of FIBROUS TISSUE 線維組織性腫瘍 線維組織性腫瘍/ 線維組織の腫瘍 1 Histological Classification of Mesenchymal Tumors of Skin and Soft Tissues of Domestic Animals 英名 提案 候補 TUMORS OF FIBROUS TISSUE 線維組織性腫瘍 線維組織性腫瘍/ 線維組織の腫瘍 1. Benign 良性 良性 1.1. Fibroma 線維腫 線維腫 膠原線維過誤腫/ 膠原線維性過誤腫/ 1.2. Collagenous hamartoma 膠原線維過誤腫 コラーゲン過誤腫 1.3. Nodular dermatofibrosis of the ジャーマンシェパードドックの結節性皮膚 German shepherd dog ジャーマンシェパードドックの結節性皮 線維症/ ジャーマン・シェパード犬の結 膚線維症 節性皮膚線維症/ジャーマンシェパード ドッグの結節性皮膚線維症 1.4. Nodular fasciitis 結節性筋膜炎 結節性筋膜炎 1.5. Myxoma 粘液腫 粘液腫 1.6. Equine sarcoid 馬サルコイド 馬サルコイド 2. Malignant 悪性 悪性 2.1. Fibrosarcoma 線維肉腫 線維肉腫 2.1.1. Feline postvaccinal 猫ワクチン接種後線維肉腫(猫ワクチ 猫ワクチン誘発性/ 猫ワクチン接種後線 ン誘発性肉腫) 維肉腫/ 猫ワクチン後 2.1.2. Canine well-differentiated 犬上顎および下顎の高分化型/ 犬高分 maxillary and mandibular 犬高分化型上顎・下顎の線維肉腫 化型上顎・下顎部線維肉腫/ 犬上顎と 下顎の高分化型 2.2. Myxosarcoma 粘液肉腫 粘液肉腫 2.3. Malignant fibrous histiocytoma 悪性線維性組織球腫 悪性線維性組織球腫 2.3.1. Storiform-pleomorphic 花むしろー多形型/ 花筵・多形型/ 花 花むしろ・多型型 むしろ・多形型 2.3.2. Inflammatory 炎症型 炎症型 2.3.3. Giant cell 巨細胞型 巨細胞型 TUMORS OF ADIPOSE TISSUE 脂肪組織性腫瘍 脂肪組織性腫瘍/ 脂肪組織の腫瘍 1. Benign 良性 良性 1.1. Lipoma 脂肪腫 脂肪腫 1.1.1. Infiltrative lipoma 浸潤性脂肪腫 浸潤性脂肪腫 1.2. Angiolipoma 血管脂肪腫 血管脂肪腫 2. Malignant 悪性 悪性 2.1. Liposarcoma 脂肪肉腫 脂肪肉腫 2.1.1. Well-differentiated 高分化型 高分化型 2.1.2. Pleomorphic 多形型 多形型 2.1.3. Myxoid 粘液型 粘液型 TUMORS OF SMOOTH MUSCLE 平滑筋性腫瘍 平滑筋性腫瘍/ 平滑筋の腫瘍 1. Benign 良性 良性 1.1. Leiomyoma 平滑筋腫 平滑筋腫 2. Malignant 悪性 悪性 2.1. Leiomyosarcoma 平滑筋肉腫 平滑筋肉腫 TUMORS OF STRIATED MUSCLE 横紋筋性腫瘍 横紋筋性腫瘍/ 横紋筋の腫瘍 1. Benign 良性 良性 1.1. Rhabdomyoma 横紋筋腫 横紋筋腫 2. Malignant 悪性 悪性 2.1. Rhabdomyosarcoma 横紋筋肉腫 横紋筋肉腫 2.1.1. Embryonal rhabdomyosarcoma 膀胱の胎児型横紋筋肉腫/ 膀胱胎子型 膀胱の胎子型横紋筋肉腫 of the urinary bladder 横紋筋肉腫/ 膀胱の胎子型横紋筋肉腫 TUMORS OF VASCULAR TISSUE 脈管組織性腫瘍 血管組織性腫瘍/ 脈管組織の腫瘍 1. Benign 良性 良性 1.1. Hemangioma 血管腫 血管腫 1.2. Lymphangioma リンパ管腫 リンパ管腫 陰嚢の血管過誤腫/ 肛門血管過誤腫/ 1.3. Scrotal vascular hamartoma 陰嚢の血管過誤腫 陰嚢の血管過誤腫 1.4. Cutaneous bovine angiomatosis 牛皮膚血管腫症 牛皮膚血管腫症 2. Intermediate 中間 中間 2.1. Kaposi-like vascular tumor カポシ様血管腫瘍/ カポシ肉腫様血管 カポジ肉腫様血管腫瘍 腫瘍 3. Malignant 悪性 悪性 3.1. Hemangiosarcoma 血管肉腫 血管肉腫 3.2. Lymphangiosarcoma リンパ管肉腫 リンパ管肉腫 3.2.1. Feline ventral abdominal 猫腹部血管肉腫/ 猫腹部腹腔内血管肉 猫腹部腹壁血管肉腫 angiosarcoma 腫/ 猫腹部腹壁血管肉腫 TUMORS OF PERIPHERAL NERVES 末梢神経性腫瘍 末梢神経性腫瘍/ 末梢神経の腫瘍 1. Benign 良性 良性 1.1. Traumatic neuroma 外傷性神経腫 外傷性神経腫 1.2. Granular cell tumor 顆粒細胞腫瘍 顆粒細胞腫/ 顆粒細胞腫瘍 1.3. Benign peripheral nerve sheath tumor 皮膚および皮下の良性末梢神経鞘腫(神 of the skin and subcutis 経線維腫、神経鞘腫(シュワン細胞腫)) [neurofibroma, schwannoma] 皮膚と皮下組織の良性末梢神経鞘腫 /皮膚および皮下組織の良性末梢神経 瘍 鞘腫瘍(神経線維腫、神経鞘腫(シュワン (神経線維腫、シュワン細胞腫) 細胞腫))/皮膚と浅在筋膜の良性末梢 神経腫瘍(神経線維腫、神経鞘腫(シュワ ン細胞腫)) 2. Malignant 悪性 悪性 2.1. Malignant peripheral nerve sheath 皮膚および皮下の悪性末梢神経鞘腫(神 tumor of the skin and subcutis 経線維肉腫、悪性神経鞘腫(悪性シュワ ン細胞腫))/ 皮膚および皮下組織の悪 [neurofibrosarcoma, malignant 皮膚と皮下組織の悪性末梢神経鞘腫 性末梢神経鞘腫瘍(神経線維肉腫、悪性 瘍 schwannoma] 神経鞘腫(悪性シュワン細胞腫))/ 皮膚 (神経線維腫、悪性シュワン細胞腫) と浅在筋膜の悪性末梢神経腫瘍(神経線 維肉腫、悪性神経鞘腫(悪性シュワン細 胞腫)) TUMORS OF SYNOVIUM 滑膜性腫瘍 滑膜性腫瘍/ 滑膜の腫瘍 1. Malignant 悪性 悪性 1.1. Synovial cell sarcoma 滑膜肉腫 滑膜肉腫/ 滑膜細胞肉腫/ 滑膜肉腫 TUMORS OF MESOTHELIUM 中皮性腫瘍 中皮性腫瘍/ 中皮の腫瘍 1. Intermediate 中間 中間 1.1. Mesothelioma 中皮腫 中皮腫 MAST CELL TUMORS 肥満細胞腫瘍 肥満細胞腫 1. Feline 猫 猫 猫”組織球性”/ 猫組織球様肥満細胞腫 1.1. Feline, "histiocytic" 猫”組織球様”(非定型的低顆粒性) / 猫”組織球性” 2. Canine 犬 犬 犬、グレードⅠ/ 犬肥満細胞腫(グレード 2.1. Canine, grade I 犬肥満細胞腫、グレードI I)/ 犬、グレードI 犬、グレードⅡ/ 犬肥満細胞腫(グレード 2.2. Canine, grade II 犬肥満細胞腫、グレードII II)/ 犬、グレードII 犬、グレードⅢ/ 犬肥満細胞腫(グレード 2.3. Canine, grade III 犬肥満細胞腫、グレードIII III)/ 犬、グレードIII 3. Other species 他の品種 他の品種/ 他の種 HISTIOCYTIC TUMORS 組織球性腫瘍 組織球性腫瘍/ 組織球系腫瘍 1. Benign 良性 良性 1.1. Canine cutaneous histiocytoma 犬皮膚組織球腫 犬皮膚組織球腫 1.2. Xanthoma 黄色腫 黄色腫 2. Intermediate 中間 中間 2.1. Cutaneous histiocytosis 皮膚組織球症 皮膚組織球症 2.2. Systemic histiocytosis 全身性組織球症 全身性組織球症 3. Malignant 悪性 悪性 悪性組織球症/ 悪性組織球症(播種性 3.1. Malignant histiocytosis 悪性組織球症(組織球性肉腫) 組織球性肉腫)/ 悪性組織球腫 MISCELLANEOUS TUMORS その他の腫瘍 その他の腫瘍/ その他 1. Benign 良性 良性 1.1. Calcinosis circumscripta 限局性石灰沈着症 限局性石灰沈着症 UNCLASSIFIED TUMORS 未分類の腫瘍 分類不能腫瘍/ 未分類の腫瘍 1. Malignant 悪性 悪性 1.1. Canine hemangiopericytoma 犬血管周皮腫 犬皮膚血管周皮腫/ 犬血管周皮腫 1.2. Malignant mesenchymoma 悪性間葉腫 悪性間葉腫 Histological Classification of Epithelial and Melanocytic Tumors of the Skin of Domestic Animals 英名 提案 候補 1. Epithelial Tumors without Squamous or 扁平上皮または皮膚付属器への分化を伴わない 扁平上皮または皮膚付属器への分化のない上皮性 Adnexal Differentiation 上皮性腫瘍 腫瘍/ 扁平上皮あるいは皮膚付属器への分化の ない上皮系腫瘍/扁平上皮あるいは皮膚付属器へ の分化を伴わない上皮性腫瘍 1.1. Basal cell tumor (basal cell 基底細胞腫(基底細胞上皮腫) 基底細胞腫(基底細胞上皮腫) epithelioma) 1.2. Basal cell carcinoma 基底細胞癌 基底細胞癌 1.2.1. Infiltrative 浸潤型 浸潤型 1.2.2. Clear cell 淡明細胞型 淡明細胞型/ 明細胞型 2. Tumors of the Epidermis 表皮の腫瘍 表皮の腫瘍 2.1. Benign 良性 良性 2.1.1. Papilloma (papillomatosis) 乳頭腫(乳頭腫症) 乳頭腫(乳頭腫症) 2.1.2. Inverted papilloma 内反性乳頭腫 内反性乳頭腫/ 内反乳頭腫 2.2. Malignant 悪性 悪性 2.2.1. Actinic keratosis (solar 光線性角化症(日光角化症) 光線角化症/ 光線性角化症(日光角化症) keratosis) 2.2.2. Multicentric squamous cell 多中心性上皮内扁平上皮癌(ボーエン病様疾患) 多中心性上皮内扁平上皮癌 / 多中心性表皮内 carcinoma in situ (Bowen-like 扁平上皮癌(ボーエン様病/ ボーエン病様疾患) disease) 2.2.3. Squamous cell carcinoma 扁平上皮癌 扁平上皮癌 2.2.4. Basosquamous carcinoma 基底有棘細胞癌/基底扁平上皮癌 基底有棘細胞癌/ 基底扁平上皮癌/ 基底扁平 細胞癌 3. Tumors with Adnexal Differentiation 皮膚付属器への分化を伴う腫瘍 皮膚付属器への分化を示す腫瘍/ 皮膚付属器分 化を伴う腫瘍 3.1. Follicular tumors 毛包の腫瘍 毛包性腫瘍/ 毛包腫瘍/ 毛包系腫瘍 Infundibular keratinizing 3.1.1. 漏斗部角化棘細胞腫 漏斗部角化棘細胞腫 acanthoma (皮内角化上皮腫,角化棘細胞腫(ケラトアカン (皮内角化上皮腫,角化棘細胞腫/ ケラトアカン (intra-cutaneous cornifying トーマ )) トーマ) epithelioma 3.1.2. Tricholemmoma 外毛根鞘腫 外毛根鞘腫 3.1.2.1. Inferior 下部型/(毛包)下部型 毛包下部型/ 下部型 3.2.2.2. Isthmic 峡部型/(毛包)峡部型 毛包峡部型/ 峡部型 3.1.3. Trichoblastoma 毛芽腫 毛芽腫 3.1.3.1. Ribbon リボン型 リボン型 3.1.3.2. Trabecular 索状型 索状型/ 小柱型 3.1.3.3. Granular cell 顆粒細胞型 顆粒細胞型 3.1.3.4. Spindle 紡錘細胞型/紡錘形細胞型 紡錘形細胞型/ 紡錘型/ 紡錘細胞型 3.1.4. Trichoepithelioma 毛包上皮腫 毛包上皮腫(毛髪上皮腫) 3.1.5. Malignant trichoepithelioma 悪性毛包上皮腫(毛母癌) 悪性毛包上皮腫(毛母癌/ 毛母基癌) (matrical carcinoma) 3.1.6. Pilomatricoma 毛母腫 毛母腫(毛母基質腫/ 毛質腫、Malherbe の壊死 (pilomatrixoma, necrotizing (毛母腫,マレルブの(壊死性)石灰化上皮腫) 性石灰化上皮腫/ マレルブの壊死性石灰化上皮 腫/ マルハルベ壊死性石灰化上皮腫) and calcifying epithelioma of Malherbe) 3.1.7. Malignant pilomatricoma 悪性毛母腫(毛母癌) 悪性毛母腫(毛母癌) (pilomatrix carcinoma) 3.2. Nailbed tumors 爪床の腫瘍 爪床の腫瘍/ 爪床腫瘍 3.2.1. Subungual keratoacanthoma 爪下角化棘細胞腫(爪下ケラトアカントーマ) 爪下角化棘細胞腫(爪下ケラトアカントーマ) (nailbed keratoacanthoma) (爪床角化棘細胞腫(ケラトアカントーマ)) (爪床角化棘細胞腫(爪床ケラトアカントーマ)) 3.2.2. Subungual squamous cell 爪下扁平上皮癌(爪床扁平上皮癌) 爪下扁平上皮癌(爪床扁平上皮癌) carcinoma ( ilb d ll 3.3. Sebaceous and modified sebaceous 脂腺および独立脂腺の腫瘍 (皮)脂腺および脂腺系の腫瘍/ 脂腺と変形脂腺 gland tumors の腫瘍 3.3.1. Sebaceous adenoma 脂腺腺腫 脂腺腺腫/ 脂腺(腺)腫 3.3.2. Sebaceous ductal adenoma 脂腺導管腺腫 脂腺腺管腫 / 脂腺導管部腺腫 3.3.3. Sebaceous epithelioma 脂腺上皮腫 脂腺上皮腫 3.3.4. Sebaceous carcinoma 脂腺癌 脂腺癌/ 脂腺(腺)癌 3.3.5. Meibomian adenoma マイボーム腺腫 マイボーム腺腫/ マイボーム腺腺腫 3.3.6. Meibomian ductal adenoma マイボーム導管腺腫 マイボーム腺腺管腫/ マイボーム導管腺腫/ マイボーム腺導管部腺腫/ マイボーム腺導管腺腫 3.3.7. Meibomian epithelioma マイボーム腺上皮腫 マイボーム腺上皮腫 3.3.8. Meibomian carcinoma マイボーム腺癌 マイボーム腺癌/ マイボーム腺(腺)癌 3.3.9. Hepatoid gland adenoma 肝様腺腺腫(肛門周囲腺腫、肛門周囲腺腫) 肛門周囲腺腫/ 肝様腺腫/ 肝様腺(腺)腫(肛門 (perianal gland adenoma, 周囲腺腫,肛門周囲腺腺腫) circumanal gland adenoma) 3.3.10 Hepatoid gland epithelioma 肝様腺上皮腫(肛門周囲腺上皮腫、肛門周囲腺上肝様腺上皮腫(肛門周囲腺上皮腫) (perianal gland epithelioma, circumanal gland epithelioma) 3.3.11 Hepatoid gland carcinoma 肝様腺癌(肛門周囲腺癌、肛門周囲腺癌) 肝様腺癌/ 肝様腺(腺)癌 (perianal gland carcinoma, (肛門周囲腺癌/ 肛門周囲腺(腺)癌) circumanal gland carcinoma) 3.4. Apocrine and modified apocrine glandアポクリン汗腺およびアポクリン腺の腫瘍 アポクリン汗腺およびアポクリン汗腺系の腫瘍/ アポクリン腺と変形アポクリン腺の腫瘍 3.4.1. Apocrine adenoma アポクリン腺腫 アポクリン汗腺腫/ アポクリン汗腺(腺)腫/ アポクリン腺(腺)腫/ アポクリン腺腺腫 3.4.2. Complex and mixed apocrine 複合および混合アポクリン腺腫 複合型および混合アポクリン汗腺腫/ 複合型・混 adenoma 合型アポクリン(汗腺)腺腫/ 複合および混合アポクリン腺(腺)腫/ 複合型と混 合型アポクリン腺腺腫 3.4.3. Apocrine ductal adenoma アポクリン導管腺腫 アポクリン汗管腫/ アポクリン導管部腺腫/ アポク リン腺導管部腺腫/ アポクリン腺導管腺腫 3.4.4. Apocrine carcinoma アポクリン腺癌 アポクリン汗腺癌/ アポクリン(汗腺)腺癌/ アポク リン腺(腺)癌/ アポクリン腺癌 3.4.5. Complex and mixed apocrine 複合および混合アポクリン腺癌 複合型および混合アポクリン汗腺癌/ 複合型・混 carcinoma 合型アポクリン腺癌/ 複合および混合アポクリン腺 (腺)癌/ 複合型と混合型アポクリン腺癌 3.4.6. Apocrine ductal carcinoma アポクリン導管癌 アポクリン汗管癌 / アポクリン導管部癌/ アポク リン腺導管部腺癌/ アポクリン腺導管癌 3.4.7. Ceruminous adenoma 耳垢腺腫 耳垢腺腫/ 耳垢腺腺腫 3.4.8. Complex and mixed 複合および混合耳垢腺腫 複合型および混合耳垢腺腫/ 複合型・混合型耳 ceruminous adenoma 垢腺腫/ 複合および混合耳垢腺(腺)腫/ 複合型 と混合型耳垢腺腺腫 3.4.9. Ceruminous gland carcinoma 耳垢腺癌 耳垢腺癌/ 耳垢腺(腺)癌/ 耳垢腺癌/ 耳垢腺 (腺)癌/ 耳垢腺癌 3.4.10 Complex and mixed 複合および混合耳垢腺癌 複合型および混合耳垢腺癌/ 複合型・混合型耳 ceruminous carcinoma 垢腺癌/ 複合および混合耳垢腺(腺)癌/ 複合型 と混合型耳垢腺癌 3.4.11 肛門嚢腺腺腫(肛門嚢アポクリン腺腺腫) 肛門傍洞腺腫(肛門嚢(の)アポクリン腺腫)/ 肛門 Anal sac gland adenoma 嚢腺腫/ 肛門嚢腺(腺)腫[肛門嚢アポクリン腺 (adenoma of the apocrine (腺)腫]/ 肛門嚢腺腺腫(肛門嚢アポクリン腺の腺 glands of the anal sac) 腫) 3.4.12 Anal sac gland carcinoma 肛門嚢腺癌(肛門嚢アポクリン腺癌) 肛門傍洞腺癌(肛門嚢のアポクリン腺癌)/ 肛門嚢 (carcinoma of the apocrine 腺癌/ 肛門嚢腺(腺)癌[肛門嚢アポクリン腺(腺) 癌]/ 肛門嚢腺癌(肛門嚢アポクリン腺の癌) glands of the anal sac) 3.5. Eccrine (atrichial) tumors エックリン汗腺(無毛汗腺)の腫瘍 エックリン腺の腫瘍/ エクリン汗腺(無毛腺)の腫瘍 / エックリン腺腫瘍(エックリン腺腫瘍) 3.5.1. Eccrine adenoma エックリン腺腫 エックリン腺腫/ エックリン腺(腺)腫/ エクリン腺 (腺)腫/ エックリン腺腺腫 3.5.2. Eccrine carcinoma エックリン腺癌 エックリン腺癌/ エックリン腺(腺)癌/ エクリン腺 (腺)癌/ エックリン腺癌 4. Tumors Metastatic to the Skin 皮膚の転移性腫瘍/皮膚への転移性腫瘍 皮膚への転移性腫瘍/ 転移性皮膚腫瘍/ 皮膚 に転移した腫瘍/ 皮膚の転移性腫瘍 5. Cysts 嚢胞 嚢胞 5.1. Infundibular cyst 毛包漏斗部型嚢胞 漏斗部型(毛包性)嚢胞/ 漏斗部嚢胞 (epidermoid cyst, epidermal cyst, (類表皮嚢胞,表皮嚢胞,表皮封入嚢胞) (類表皮嚢胞,表皮嚢胞,表皮封入嚢胞) epidermal inclusion cyst) 5.2. Dilated pore 毛孔拡大腫 毛孔拡大腫 5.3. Isthmus cyst 毛包峡部型嚢胞 峡部型(毛包性)嚢胞/ 峡部型嚢胞/ 峡部嚢胞 5.4. Panfollicular (trichoepitheliomatous) 汎毛包性(毛包上皮腫様)嚢胞 汎毛包性(毛包上皮腫様)嚢胞 5.5. Dermoid cyst (dermoid sinus) 類皮嚢腫(類皮洞) 類皮嚢腫(類皮洞)/ 類皮嚢腫/ 類皮嚢胞(類皮 腫洞)/ 類皮嚢腫、皮様嚢腫(類皮洞、皮様洞) 5.6. Sebaceous duct cyst 脂腺導管嚢胞 脂腺管嚢胞/ 脂腺導管部嚢腫/ 脂腺導管嚢胞 5.7. Apocrine cyst(s) (apocrine cystomatosアポクリン嚢腫(アポクリン嚢腫症) アポクリン嚢腫/ アポクリン腺嚢胞 (アポクリン嚢腫症/ アポクリン嚢胞腺腫症/ アポ クリン腺嚢胞腫症) 5.8. Ciliated cyst 線毛上皮嚢胞 線毛上皮性嚢胞/ 線毛嚢腫/ 線毛性嚢胞/ 線 毛上皮嚢胞 5.9. Subungual epithelial inclusion cyst 爪下上皮封入嚢胞 爪下上皮性封入嚢胞/ 爪下上皮封入嚢胞 6. Hamartomas 過誤腫 過誤腫 6.1. Epidermal hamartoma (pigmented 表皮過誤腫(色素性表皮母斑) 表皮過誤腫(色素沈着性表皮母斑/ 色素性表皮 epidermal nevus) 母斑) 6.2. Follicular hamartoma 毛包過誤腫 毛包過誤腫 6.3. Sebaceous hamartoma 脂腺過誤腫 脂腺過誤腫 6.4. Apocrine hamartoma アポクリン腺過誤腫 アポクリン腺過誤腫 6.5. Fibroadnexal hamartoma 線維付属器過誤腫 線維性皮膚付属器過誤腫/ 線維付属器過誤腫 (adnexal nevus, focal adnexal ((皮膚)付属器母斑、限局性付属器異形成、毛 (皮膚付属器母斑/ 付属器過誤腫/ 付属器母 包脂腺過誤腫) 斑,限局性皮膚付属器異形成/ 限局性付属器異 dysplasia, folliculosebaceous 形成,毛包皮脂腺過誤腫/ 毛包脂腺過誤腫) 7. Tumor-likeht) Lesions 腫瘍類似病変/腫瘍様病変 腫瘍類似病変/ 腫瘍様変化 7.1. Squamous papilloma 扁平上皮乳頭腫 扁平上皮乳頭腫 7.2.
Recommended publications
  • Practical Veterinary Dermatopathology for the Small Animal Clinician
    Dermatopathology_FINAL.qxd 2/14/06 11:19 AM Page i Practical Veterinary Dermatopathology for the Small Animal Clinician Sonya V. Bettenay, BVSc Dip. Ed, MACVSc, FACVSc CSU Diagnostic Laboratory Dermatopathology Service Department of Clinical Sciences Colorado State University Fort Collins, CO Ann M. Hargis, DVM, MS Diplomate, ACVP DermatoDiagnostics, Edmonds, WA Department of Comparative Medicine University of Washington, Seattle, WA Phoenix Central Laboratory Everett, WA Jackson,Wyoming www.veterinarywire.com Teton NewMedia Teton NewMedia 90 East Simpson, Suite 110 Jackson, WY 83001 © 2003 by Tenton NewMedia Exclusive worldwide distribution by CRC Press an imprint of Taylor & Francis Group, an Informa business Version Date: 20140103 International Standard Book Number-13: 978-1-4822-4128-0 (eBook - PDF) This book contains information obtained from authentic and highly regarded sources. While all reasonable efforts have been made to publish reliable data and information, neither the author[s] nor the publisher can accept any legal responsibility or liability for any errors or omissions that may be made. The publishers wish to make clear that any views or opinions expressed in this book by individual editors, authors or contributors are personal to them and do not necessarily reflect the views/opinions of the publishers. The information or guidance contained in this book is intended for use by medical, scientific or health-care professionals and is provided strictly as a supplement to the medical or other professional’s own judgement, their knowledge of the patient’s medical history, relevant manufacturer’s instructions and the appropriate best practice guide- lines. Because of the rapid advances in medical science, any information or advice on dosages, procedures or diagnoses should be independently verified.
    [Show full text]
  • Rotana Alsaggaf, MS
    Neoplasms and Factors Associated with Their Development in Patients Diagnosed with Myotonic Dystrophy Type I Item Type dissertation Authors Alsaggaf, Rotana Publication Date 2018 Abstract Background. Recent epidemiological studies have provided evidence that myotonic dystrophy type I (DM1) patients are at excess risk of cancer, but inconsistencies in reported cancer sites exist. The risk of benign tumors and contributing factors to tu... Keywords Cancer; Tumors; Cataract; Comorbidity; Diabetes Mellitus; Myotonic Dystrophy; Neoplasms; Thyroid Diseases Download date 07/10/2021 07:06:48 Link to Item http://hdl.handle.net/10713/7926 Rotana Alsaggaf, M.S. Pre-doctoral Fellow - Clinical Genetics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, NIH PhD Candidate – Department of Epidemiology & Public Health, University of Maryland, Baltimore Contact Information Business Address 9609 Medical Center Drive, 6E530 Rockville, MD 20850 Business Phone 240-276-6402 Emails [email protected] [email protected] Education University of Maryland – Baltimore, Baltimore, MD Ongoing Ph.D. Epidemiology Expected graduation: May 2018 2015 M.S. Epidemiology & Preventive Medicine Concentration: Human Genetics 2014 GradCert. Research Ethics Colorado State University, Fort Collins, CO 2009 B.S. Biological Science Minor: Biomedical Sciences 2009 Cert. Biomedical Engineering Interdisciplinary studies program Professional Experience Research Experience 2016 – present Pre-doctoral Fellow National Cancer Institute, National Institutes
    [Show full text]
  • Glandular Tumors of the External Auditory Canal*>
    Hiroshima Journal of Medical Sciences 17 VoL 33, No. 1, 17,.._,22, March, 1984 HIJM 33-3 Glandular Tumors of the External Auditory Canal*> Toshio TANAKA1 >, Ryusuke SAITQ2>, Motomasa ISHIHARA2 >, Takuya OHMICHI2> and Yoshio OGURA2> 1 ) Pathology Section, Central Laboratories, Okayama University Medical School, Oka­ yama 700, Japan 2 ) Department of Otorhinolaryngology, Okayama University Medical School, Okayama 700, Japan (Received November 29, 1983) Key words: Ceruminous gland tumor, Metastatic tumor, External auditory canal ABSTRACT We reported one case each of mixed tumor and adenoid cystic carcinoma originating in the external auditory canal, and one case of adenocarcinoma of the thyroid with the initial manifestation of symptoms in the otologic field eight years after the thyroi­ dectomy. Major literature concerning ceruminous gland tumors were reviewed, and almost identical pathologic findings of ceruminous gland tumors to conventional sweat gland tumors, caution against metastatic cancers to the external auditory canal, the criteria of malignancy of ceruminous gland tumors and its unique biologic behavior were discussed. necropsy confirmed its metastatic origin. These INTRODUCTION three cases were experienced in recent six-year Haug51 in 1894 reported a ceruminous adeno­ period. ma and a case of what appeared to be adenoid cystic carcinoma as die Neubildungen des aus­ CASE PRESENTATION seren und mittleren Ohres. Since then, sporadic Case 1: This is a 52-year-old male com­ cases have appeared under various termino­ plaining of the left ear obstruction of two to logies, such as ceruminoma, hidradenoma, cylin­ three months' duration. A tumor was situated droma, myoepithelioma, mixed tumor, pleomor­ about 0. 5 to 1.
    [Show full text]
  • Ceruminous Adenoma of the External Auditory Canal - Report of Two Cases
    대한두경부종양학회지 제 25 권 제 2 호 2009 online © ML Comm Ceruminous Adenoma of the External Auditory Canal - Report of Two Cases - Na Rae Kim, MD1, Kyu Cheol Han, MD2, Hee Young Hwang, MD3, Hyun Yee Cho, MD1 Departments of Pathology,1 Otolaryngology2 and Radiology,3 Gachon University Gil Hospital, Incheon, Korea 외이도의 귀지샘종 - 2예 보고 - 가천의과학대학교 길병원 병리과,1 이비인후과,2 영상의학과3 김나래1·한규철2·황희영3·조현이1 = 국 문 초 록 = 외이도의 종양은 드물며, 귀지샘에서 기원한 종양은 더욱 흔하지 않다. 저자들은 이루를 동반한 2예의 귀지샘종을 보 고하고자 한다. 현미경적으로, 2예 모두 중층 혹은 단층으로 둘러싸인 세관 혹은 샘으로 이루어진 경계가 좋은 종양이었 다. 종양세포는 과립성의 풍부한 호산성 세포질을 가졌고, 세포질의 관내 돌출이 관찰되어 아포크린화생을 보였다. 완전 절제후 재발은 관찰되지 않았다. 귀지샘종은 경계가 좋은 양성종양이며, 광범위 절제 치료하지만, 높은 재발율을 보인다. 여기에서 외이도에서 발생한 귀지샘종의 임상적 소견과 함께 병리 소견에 대해 기술하였다. 중심 단어:귀지샘종·외이도. Here, we report on two cases of ceruminous adenoma that Introduction originated in the external auditory canal, and briefly describe the clinical features and surgical treatment. The external auditory canal is divided into the inner osse- ous(2/3) and the outer cartilaginous portions(1/3). The skin Case Report of the bony portion contains few appendages, and the skin of the cartilaginous portion shows numerous hair follicles, Case 1 was is a 53-year-old male who suffered from inter- sebaceous glands and a modified apocrine sweat gland, i.e., mittent otorrhea in the right ear for 1 year. A protruding mass the ceruminous gland. This gland is found in the deep der- was detected at the cartilagenous portion of the right exter- mis of the overlying skin lining the cartilaginous portion of nal auditory canal.
    [Show full text]
  • A Case Report of Ceruminous Adenocarcinoma of External Auditory Canal
    East African Scholars Multidisciplinary Bulletin Abbreviated Key Title: East African Scholars Multidiscip Bull ISSN 2617-4413 (Print) | ISSN 2617-717X (Online) | Published By East African Scholars Publisher, Kenya DOI: 10.36349/easmb.2019.v02i08.012 Volume-2 | Issue-8 | Aug-2019 | Case Report A Case Report of Ceruminous Adenocarcinoma of External Auditory Canal Dr.Roshan A. Mathew1*, Dr.Sankar S1 and Dr.Lillykuty Pothen1 1Dept.of pathology Govt medical college Kottayam, Kerala, India *Corresponding Author Dr.Roshan A. Mathew Abstract: The external auditory canal contains ceruminous glands, which are modified apocrine sweat glands, along with sebaceous glands. Tumors that originate from ceruminous glands are very rare; thus, the classification, clinical behavior, and management of these tumors remain debatable. Here we present a case of ceruminous adenocarcinoma arising from the external auditory canal with all the mandatory histological features. Although most authors advise more aggressive therapy, our patient was treated with local en bloc resection of the tumor followed by intensity modulated radiotherapy. Keywords: Ear neoplasms, adenocarcinoma, ear canal. INTRODUCTION ceruminous adenocarcinoma of EAC, which presented The ceruminous glands are modified apocrine as a polypoid mass. The patient was treated with local glands located within the dermis of the skin overlaying en bloc resection of the tumor and followed by the cartilaginous portion of the external auditory canal radiotherapy. (EAC) (Iqbal, A., & Newman, P. 1998). Watery secretions of ceruminous glands, along with sebaceous CASE PRESENTATION gland secretions, are drained into the hair sacs of fine A male patient aged 51 years, presented with hairs in EAC, together forming the cerumen (wax) history of left ear discharge of 1 year and left ear block (Thompson, L.D.
    [Show full text]
  • Histological and Immunohistochemical Practical Studies of Canine Cutaneous Tumors
    Med. Weter. 2016, 72 (9), 571-579 DOI: 10.21521/mw.5558 571 Praca oryginalna Original paper Histological and immunohistochemical practical studies of canine cutaneous tumors DONATAS ŠIMKUS, SAULIUS PETKEVIČIUS, GEDIMINAS PRIDOTKAS*, LIGITA ZORGEVICA-POCKEVIČA**, VIKTORAS MASKALIOVAS*, VIRGINIJA ŠIMKIENĖ*, ALIUS POCKEVIČIUS Department of Infectious Diseases, Veterinary Academy, Lithuanian University of Health Sciences, Tilzes Str. 18, LT-47130 Kaunas, Lithuania *National Food and Veterinary Risk Assessment Institute, J. Kairiukscio Str. 10, LT-08409 Vilnius, Lithuania **Dr. L Kriaučeliūnas Small Animal Clinic, Veterinary Academy, Lithuanian University of Health Sciences, Tilzes Str. 18, LT-47130 Kaunas, Lithuania Received 20.01.2016 Accepted15.06.2016 Šimkus D., Petkevičius S., Pridotkas G., Zorgevica-Pockeviča L., Maskaliovas V., Šimkienė V., Pockevičius A. Histological and immunohistochemical practical studies of canine cutaneous tumors Summary A total of one hundred and fifty-three canine cutaneous tumors were examined and analyzed using the standard haematoxylin-eosin staining method. Additionally, tumors were examined immunohistochemically (41.4%) with antibodies LP34, AE1/AE3, V9 and histochemically (24.8%) with toluidine blue. Epithelial and melanocytic tumors of the skin accounted for 52.3% and mesenchymal tumours constituted 47.7%. All epidermal and follicular tumors demonstrated positive immunostaining for “LP34” antibodies. Fibromas and fibrosarcomas, which were immunohistochemically positive for antibodies “V9”, demonstrated negative immunostaining for antibodies “LP34”. As many as 47.4% of all round cell tumors showed positive staining with toluidine blue. Antibodies “LP34” are helpful for the differential diagnosis of epithelial cells of tumors in canine skin, skin adnexal and subcutaneous tissues. Antibodies “AE1/AE3” could be helpful for detecting metastatic glandular epithelial cells in the skin.
    [Show full text]
  • Instytu, Warszawa
    Międzynarodowa Klasyfikacja Chorób I dla Onkologii C Trzecia edycja Edytorzy wydania polskiego Urszula Wojciechowska Krajowy Rejestr Nowotworów D Centrum Onkologii – Instytut, Warszawa Beata Kościańska Centrum Onkologii Ziemi Lubelskiej, Lublin Monika Nowaczyk Pomorskie Centrum Onkologii, Gdańsk - Konsultacje Dr n. med. Danuta Skomra Uniwersytet Medyczny w Lublinie O Dr n. med. Franciszek Szubstarski Centrum Onkologii Ziemi Lubelskie, Lublin Dr n. med. Grzegorz Rymkiewicz Centrum Onkologii – Instytu, Warszawa Dr n. med. Bożena Jarosz Uniwersytet Medyczny w Lublinie Dr n. med. Artur Antolak Specjalistyczny Szpital Św. Wojciecha w Gdańsku Dr hab med Zbigniew Nowecki Centrum Onkologii – Instytu, Warszawa Centrum Onkologii – Instytut, Warszawa 2007 Publikacja sfinansowana ze środków Narodowego Programu Zwalczania Chorób Nowotworowych w ramach zadania: „Poprawa działania systemu zbierania i rejestrowania danych o nowotworach złośliwych” Tłumaczenie publokacji wydanej przez Światową Organizację Zdrowia pod tytułem: International Classification of Diseases for Oncology, third edition Edytorzy wydania angielojęzycznego April Fritz and Constance Percy National Cancer Institute, Bethesda, MD, USA Dr. Andrew Jack Leeds Teaching Hospitals, Leeds, United Kingdom Dr. K. Shanmugaratnam National University of Singapore, Singapore Dr. Leslie Sobin Armed Forces Institute of Pathology, Washington, DC, USA Dr. D. Max Parkin and Sharon Whelan International Agency for Research on Cancer, Lyon, France ISBN ISBN 83-88681-46-X EAN 9788388681462 Wydawnictwo: Weda
    [Show full text]
  • Trichofolliculoma of the External Auditory Canal in a Pediatric Patient
    Open Journal of Clinical & Medical Volume 1 (2015) Issue 7 Case Reports ISSN 2379-1039 Trichofolliculoma of the External Auditory Canal in a Pediatric Patient Syed A Ali, MD; Charles A Elmaraghy, MD; Bonita Fung, MD, Benjamin Feldman, MD; Kris R Jatana, MD* *Kris R Jatana, MD Department of Otolaryngology-Head & Neck Surgery, Wexner Medical Center at Ohio State University, Columbus, Ohio, USA Department of Pediatric Otolaryngology-Head & Neck Surgery, Nationwide Children's Hospital, Columbus, Ohio. Email: [email protected] Abstract Trichofolliculoma is a rare occurrence in children, and more speciically in the head and neck region, with the majority of cases describing central facial growths. We present a case of a 7-year old girl who presented with bloody otorrhea, aural fullness, and otalgia, in the irst pediatric report of trichofolliculoma of the external auditory canal. Magnetic resonance imaging revealed a smooth mass illing the external auditory canal, and histology demonstrated a hamartomatous growth with partial hair follicle differentiation. This case emphasizes the inclusion of trichofolliculoma in the differential diagnoses of children with ear masses, with surgical resection being a curative option. Keywords Pediatric, Trichofolliculoma, External auditory canal, Hamartoma Introduction Trichofolliculoma (TF) is a rare, benign adnexal hamartoma of the hair follicle within the skin that typically occurs in adults. Institutional review board approval was obtained, and to our knowledge, we describe the irst pediatric case of TF in the external auditory canal (EAC). Case Presentation A 7 year-old girl presented one week after digital manipulation of the ear canal led to transient bloody otorrhea and otalgia.
    [Show full text]
  • Epidemiology of Skin Tumor Entities According to the New Who Classification
    S EPIDEMIOLOGY OF E I T I SKIN TUMOR ENTITIES T N ACCORDING TO THE NEW WHO E R CLASSIFICATION O M IN DOGS AND CATS U T N I K S F O Monier A. Mohamed Sharif Y G O L O I M E D I P E F I R A H S INAUGURAL-DISSERTATION R E zur Erlangung des Grades eines I Dr. med. vet. N beim Fachbereich Veterinärmedizin édition scientifique O VVB LAUFERSWEILER VERLAG der Justus-Liebig-Universität Gießen M VVB LAUFERSWEILER VERLAG ISBN 3-8359-5055-X STAUFENBERGRING 15 D-35396 GIESSEN Tel: 0641-5599888 Fax: -5599890 [email protected] www.doktorverlag.de 9 7 8 3 8 3 5 9 5 0 5 5 9 édition scientifique VVB VVB LAUFERSWEILER VERLAG Das Werk ist in allen seinen Teilen urheberrechtlich geschützt. Jede Verwertung ist ohne schriftliche Zustimmung des Autors oder des Verlages unzulässig. Das gilt insbesondere für Vervielfältigungen, Übersetzungen, Mikroverfilmungen und die Einspeicherung in und Verarbeitung durch elektronische Systeme. 1. Auflage 2006 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of the Author or the Publishers. 1st Edition 2006 © 2006 by VVB LAUFERSWEILER VERLAG, Giessen Printed in Germany VVB LAUFERSWEILER VERLAG édition scientifique STAUFENBERGRING 15, D-35396 GIESSEN Tel: 0641-5599888 Fax: 0641-5599890 email: [email protected] www.doktorverlag.de Aus Institut für Veterinär-Pathologie der Justus-Liebig-Universität Giessen Betreuer: Prof. Dr. Manfred Reinacher, Geschäftsführender Direktor des Institut für Veterinär-Pathologie der Justus-Liebig-Universität Giessen EPIDEMIOLOGY OF SKIN TUMOR ENTITIES ACCORDING TO THE NEW WHO CLASSIFICATION IN DOGS AND CATS INAUGURAL-DISSERTATION zur Erlangung des Grades eines Dr.
    [Show full text]
  • Pleomorphic Adenoma of External Auditory Canal: Case Report of First Endoscopic Resection and Literature Review
    medicina Case Report Pleomorphic Adenoma of External Auditory Canal: Case Report of First Endoscopic Resection and Literature Review 1 2 1 1, , Sven Beckmann , Matthias S. Dettmer , Marco D. Caversaccio , Roland Giger * y and Lukas Anschuetz 1 1 Department of Otorhinolaryngology, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland; [email protected] (S.B.); [email protected] (M.D.C.); [email protected] (L.A.) 2 Institute of Pathology, University of Bern, 3010 Bern, Switzerland; [email protected] * Correspondence: [email protected]; Tel.: +41-31-632-29-31; Fax: +41-31-632-88-09 Equal last shared authorship. y Received: 7 April 2020; Accepted: 15 May 2020; Published: 20 May 2020 Abstract: Ceruminous pleomorphic adenoma is a very rare, mostly benign tumor originating from the ceruminal glands in the external auditory canal. Histologically, it is a mixed tumor with epithelial and stromal parts of different proportions, and is recognized today by the World Health Organization (WHO) as a ceruminous adenoma. Similar to the pleomorphic adenoma of salivary glands, recurrence or malignant degeneration with cellular atypia and metastasis can occur on rare occasions. Here, we describe an 87-year old female patient with a growing spherical mass in the right external auditory canal. After exclusive endoscopic tumor resection, a ceruminous pleomorphic adenoma was histologically diagnosed. Due to the absence of nuclear pleomorphism, no increased mitotic rate, no perineural invasion and no fusion transcripts of the MYB or MYBL1 gene loci, an adenoid cystic carcinoma could be excluded. The postoperative course was without any evidence of complications.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2017/0119913 A1 Osterkamp Et Al
    US 201701 1991.3A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2017/0119913 A1 Osterkamp et al. (43) Pub. Date: May 4, 2017 (54) CONJUGATE COMPRISINGA the first targeting moiety is capable of binding to a first NEUROTENSIN RECEPTOR LIGAND AND target, AD1 is a first adapter moiety or is absent, LM is a USE THEREOF linker moiety or is absent, AD2 is a second adapter moiety or is absent, and TM2 is a second targeting moiety, wherein (71) Applicant: 3B PHARMACEUTICALS GMBH, the second targeting moiety is capable of binding to a second target; wherein the first targeting moiety and/or the second Berlin (DE) targeting moiety is a compound of formula (2): wherein R' (72) Inventors: Frank Osterkamp, Berlin (DE); is selected from the group consisting of hydrogen, methyl Christian Haase, Berlin (DE); Ulrich and cyclopropylmethyl: AA-COOH is an amino acid Reineke, Berlin (DE); Christiane selected from the group consisting of 2-amino-2 adamantane Smerling, Berlin (DE); Matthias carboxylic acid, cyclohexylglycine and 9-amino-bicyclo3. Paschke, Berlin (DE); Jan Ungewi?, 3.1 nonane-9 carboxylic acid; R is selected from the group Berlin (DE) consisting of (C-C)alkyl, (C-C)cycloalkyl, (CCs)cy cloalkylmethyl, halogen, nitro and trifluoromethyl: ALK" is (21) Appl. No.: 15/317,598 (C-Cs)alkylidene, R, R and R are each and indepen dently selected from the group consisting of hydrogen and (22) PCT Filed: Jun. 10, 2015 (C-C)alkyl under the proviso that one of R, R and R is of the following formula (3) wherein ALK" is (C-Cs) (86).
    [Show full text]
  • Histopathology IMPC HIS 001
    Histopathology IMPC_HIS_001 Purpose To perform histopathological examination and annotation on the standard list of tissues (see SOPs for IMPC Gross pathology & Tissue Collection) using the tissue orientation laid out in the SOP for IMPC Tissue Embedding & Block Banking. Experimental Design Minimum number of animals : 2M + 2F Age at test: Week 16 Notes Significance Score Not significant . Interpreted by the histopathologist to be a finding attributable to background strain (e.g. low- incidence hydrocephalus, microphthalmia) or incidental to mutant phenotype (e.g. hair- induced glossitis, focal hyperplasia, mild mononuclear cell infiltrate). OR Significant . Interpreted by the histopathologist as a finding not attributable to background strain and not incidental to mutant phenotype. Severity Score Sc Term Definition ore No lesion(s) or abnormalities detectable considering the age and sex of 0 Normal the animal Abnormality visible, involving single or multiple tissue types in a minimal 1 Mild proportion of an organ, likely to have no functional consequence 2 Moder Abnormality visible, involving multiple tissue types in a minority proportion ate of an organ, likely to have no clinical consequence (subclinical) Abnormality clearly visible, involving multiple tissue types in a majority 3 Marked proportion of an organ, likely to have minor clinical manifestation(s) Abnormality clearly visible, involving multiple tissue types in almost all 4 Severe visible area of an organ, likely to have major clinical manifestation(s) Parameters and Metadata
    [Show full text]